ETAGCLU Trademark

Trademark Overview

On Wednesday, July 21, 2021, a trademark application was filed for ETAGCLU with the United States Patent and Trademark Office. The USPTO has given the ETAGCLU trademark a serial number of 90840013. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, July 2, 2024. This trademark is owned by Astellas Pharma Inc.. The ETAGCLU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
etagclu

General Information

Serial Number90840013
Word MarkETAGCLU
Filing DateWednesday, July 21, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Saturday, July 24, 2021NEW APPLICATION ENTERED
Wednesday, September 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2022ASSIGNED TO EXAMINER
Monday, April 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022SOU EXTENSION 1 FILED
Tuesday, December 20, 2022SOU EXTENSION 1 GRANTED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 2 FILED
Monday, June 26, 2023SOU EXTENSION 2 GRANTED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024SOU EXTENSION 3 GRANTED
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 3 FILED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 2, 2024SOU EXTENSION 4 FILED

Related Keywords

etagclu cancer treatment preparations pharmaceutical